| ID | DRAMP21404 |
|---|---|
| Sequence | ITKVITKLLNRLTKILSK |
| Length | 18 |
| Name | peptide 2 (De Novo Synthesis) |
| Source | synthetic construct |
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram- |
| Pathogen | [Ref.31117348] Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC=15 ± 2.5μM), Bacillus subtilis ATCC 6633(MIC=15 ± 2.5μM);##Gram-negative bacteria:Escherichia coli ATCC 15597(MIC=3.1μM), Pseudomonas aeruginosa (MIC=25μM), Salmonella Typhimurium 6192(MIC=40 ± 5μM), Klebsiella pneumoniae NCTC 5055(MIC=50μM) |
| Hemolytic Activity | [Ref.31117348] 5% hemolysis at 250 μM against human blood cells. |
| Cytotoxicity | [Ref.31117348] ①The cell viability of MCF7 cells induced by peptide 2 is 94.2%, 88.6%, 82.0%, 55.0%, 44.0%, 32.4%, 15.3%, 15.8%, 12.8% and 1.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=22.5±0.7 μM. ②The cell viability of Hela cells induced by peptide 2 is 96.1%, 95.4%, 83.8%, 64.2%, 57.7%, 49.5%, 31.5%, 30.2%, 7.8% and 0.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=29.8±1 μM. ③The cell viabiity of HDF cells induced by peptide 2 is 96.3%, 89.7%, 89.9%, 92.7%, 95.0%, 93.4%, 93.1%, 96.1%, 88.6% and 67.4% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Linear/Cyclic/Branched | Linear |
| Uniprot | |
| PDB | |
| 3D View | |
| PDB Download | Download PDB Predicted by Alphafold2 |
| PubMed ID | 31117348 |
Physicochemical Properties
| Residues | 18 |
|---|---|
| Sequence | ITKVITKLLNRLTKILSK |
| Molecular Weight | 2082.616 |
| Grand Average of Hydropathy | 0.356 |
| Isoelectric Point | 11.334 |
| Charge at pH 7.4 | 4.547 |
| Secondary Structure | Helix: 0.444, Turn: 0.111, Sheet: 0.222 |
| Instability Index | 5.994 |
| Aromaticity | 0 |
